date on January 1, 2020. By this summarization of business operation and financial statement of year 2019 was prepared under standard before the change and does not have retrospective improvements on

Operating Results of the Company in Q2/2020 Q2/18 Q2/19 1H/18 1H/19 Change +/(-) (THB million) YoY 1H Operating Revenue 312 144 (54%) 599 363 (39%) Gross Profit 201 79 (61%) 389 216 (44%) EBITDA 95 27 (72

following table. (Unit: Million Baht) Q2/2016 Q2/2017 Y-O-Y Change Increase/(Decrease) Note Sales Revenue 213.2 196.4 (7.9%) The company's sales revenue for Q2/2017 was THB 196.4 mn and classified from the

international sales declined dramatically at 46.03% compared to the same period of the previous year. One of the issues was the delayed product delivery after the license was issued from China Food and Drug

Summary of operations and the factors that make a significant change Summary of Operations for the Year 2018 Topic Annual Balance Change 2018 2017 2018 VS 2017 (MB) (MB) % Total Revenue 4,237.6 5,397.2

of useful lives with reference to the Health Study Report from an independent engineering expert and the repair and maintenance of buildings, machinery and equipment. This is considered the Change in

as highlighted below ; (Unit : Million Baht) Separate financial statements 2017 2016 % Change Sales and Service Income 1,979.16 1,986.34 -0.36 Cost of sales and Services 1,525.25 1,449.23 +5.25 Selling

150.24 million, whereas Baht 21.63 million in 2018, showing a decrease of Baht 128.61 million or representing 594.59 % increase since there have been 2 projects delivery complete in the period. Therefore

margin was higher as the company could be Revenues Gross Profit Selling Admin Net profit 3Q/17 185,920 62,255 17,599 18,053 19,079 3Q/18 249,407 89,092 21,509 18,502 32,736 Change 63,487 26,837 3,910 449

% 2.2% 29.9% 27.2% (2.7%) Net profit margin1 (%) 17.7% 8.1% (9.6%) 19.7% 7.1% (12.6%) Number of branches as at Dec 312 38 39 3% 38 39 3% 2019 2020 Change +/(-) Change +/(-) Q4/19 Q4/20 Operating highlight